| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $8.1M | -25.3% |
| SG&A Expense | $4.2M | -12.4% |
| Operating Income | -$12.3M | +21.3% |
| Pre-tax Income | -$12.2M | +23.3% |
| Net Income | -$12.2M | +23.3% |
| EPS (Basic) | -$1.11 | +42.2% |
| EPS (Diluted) | -$1.11 | +42.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $7.0M | -49.8% |
| Current Assets | $8.4M | -46.9% |
| Total Assets | $8.4M | -46.9% |
| Current Liabilities | $1.0M | -18.2% |
| Total Liabilities | $1.0M | -18.2% |
| Stockholders' Equity | $7.3M | -49.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$11.5M | +26.9% |
| Financing Cash Flow | $4.5M | +4700.8% |